Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: A randomized controlled trial

Schizophrenia Research

Volumn 150, Issue 1, 2013, Pages 240-244

  Komatsu, Hideki ^a   Sekine, Yoshimoto ^a   Okamura, Naoe ^a   Kanahara, Nobuhisa ^a   Okita, Kyoji ^a   Matsubara, Saburo ^b   Hirata, Toyoaki ^c   Komiyama, Tokutaro ^d   Watanabe, Hiroyuki ^e   Minabe, Yoshio ^f   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Matsubara Hospital Neuropsychiatric Institute   (Japan)

^c Shizuoka Psychiatric Medical Center   (Japan)

^d Iida Hospital   (Japan)

^e ASAHI GENERAL HOSPITAL   (Japan)

^f KANAZAWA UNIVERSITY   (Japan)

Author keywords

Information technology; ITAREPS; Relapse prevention; Schizophrenia; Visiting nurse

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EARLY INTERVENTION; FEMALE; HAZARD RATIO; HEALTH PROGRAM; HEALTH STATUS; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INFORMATION TECHNOLOGY AIDED RELAPSE PREVENTION PROGRAMME; MAINTENANCE DRUG DOSE; MALE; MEDICAL INFORMATICS; MEDICATION COMPLIANCE; MULTICENTER STUDY; NUMBERS NEEDED TO TREAT; OPEN STUDY; OUTPATIENT; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROSPECTIVE STUDY; PROTOCOL COMPLIANCE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK ASSESSMENT; SCHIZOPHRENIA; VISITING NURSING SERVICE;

INFORMATION TECHNOLOGY; ITAREPS; RELAPSE PREVENTION; SCHIZOPHRENIA; VISITING NURSE;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HOSPITALIZATION; HUMANS; JAPAN; MALE; MEDICAL INFORMATICS; MIDDLE AGED; OUTPATIENTS; PATIENT READMISSION; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 84884142844     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.08.007     Document Type: Article

References (15)

1. Gleeson J.F., Alvarez-Jimenez M., Cotton S.M., Parker A.G., Hetrick S. A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis. Schizophr. Res. 2010, 119(1-3):79-88.
2. Ho B.C., Andreasen N.C., Ziebell S., Pierson R., Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 2011, 68(2):128-137.
3. Keith S. Advances in psychotropic formulations. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30(6):996-1008.
4. Leucht S., Tardy M., Komossa K., Heres S., Kissling W., Salanti G., Davis J.M. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet 2012, 379(9831):2063-2071.
5. Mathalon D.H., Sullivan E.V., Lim K.O., Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 2001, 58(2):148-157.
6. McGlashan T.H. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr. Bull. 1988, 14(4):515-542.
7. Robinson D., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., Lieberman J.A. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 1999, 56(3):241-247.
8. Španiel F., Hrdlička J., Novák T., Kožený J., Höschl C., Mohr P., Motlová L.B. Effectiveness of the information technology-aided program of relapse prevention in schizophrenia (ITAREPS): a randomized, controlled, double-blind study. J. Psychiatr. Pract. 2012, 18(4):269-280.
9. Španiel F., Vohlídka P., Hrdlicka J., Kozený J., Novák T., Motlová L., Cermák J., Bednarík J., Novák D., Höschl C. ITAREPS: Information Technology Aided Relapse Prevention Programme in Schizophrenia. Schizophr. Res. 2008, 98(1-3):312-317.
10. Španiel F., Vohlídka P., Kozený J., Novák T., Hrdlicka J., Motlová L., Cermák J., Höschl C. The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up. Int. J. Clin. Pract. 2008, 62(12):1943-1946.
11. Takeuchi H., Suzuki T., Uchida H., Watanabe K., Mimura M. Antipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithms. Schizophr. Res. 2012, 134(2-3):219-225.
12. Tiihonen J., Haukka J., Taylor M., Haddad P.M., Patel M.X., Korhonen P. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am. J. Psychiatry 2011, 168(6):603-609.
13. Volavka J. ITAREPS relapse prevention in schizophrenia. Int. J. Clin. Pract. 2008, 62(12):1824-1825.
14. Wiersma D., Nienhuis F.J., Slooff C.J., Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr. Bull. 1998, 24(1):75-85.
15. Xia J., Merinder L.B., Belgamwar M.R. Psychoeducation for schizophrenia. Cochrane Database Syst. Rev. 2011, (6):CD002831.